InvestorsHub Logo
Followers 10
Posts 217
Boards Moderated 0
Alias Born 01/24/2020

Re: None

Friday, 08/21/2020 10:33:34 AM

Friday, August 21, 2020 10:33:34 AM

Post# of 346054
A PS Targeting vaccine message

“PS Targeting collaborations with OXiGene to dozens others, as MabVax approval nears with Memorial Sloan Kettering shocked as to how impressive PS Targeting eliminates off target toxicities and adjuvant mix in with vaccine ...Nicholas Green & Avid Bio teaming up with Steve King would officially foil all of some plans of past”

HOLD for $500 per share
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News